Oetgen Stephen Duane bought ARXS
April 17, 2026 · Form 4 insider transaction
Oetgen Stephen Duane bought 25,000 shares of Arxis, Inc. at $28.00 per share, a transaction worth $700.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$28.00
Total value
$700.0K
InsiderOetgen Stephen Duane
RoleDirector
CompanyArxis, Inc. (ARXS)
SecurityClass A Common Stock
Transaction codeP: Open-market purchase
Transaction dateApril 17, 2026
Filing dateApril 20, 2026
Shares owned after30,357
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of Class A Common Stock purchased by the Reporting Person through the directed share program conducted in connection with the Issuer's initial public offering.